• Syros Pharmaceuticals (NASDAQ:SYRS) Receives Hold Rating from Brookline Capital Management

    Источник: Buzz FX / 13 ноя 2024 08:56:17   America/New_York


    Syros Pharmaceuticals (NASDAQ:SYRS) Receives Hold Rating from Brookline Capital Management Written by MarketBeat November 13, 2024 Share Link copied to clipboard. Syros Pharmaceuticals ( NASDAQ:SYRS - Get Free Report ) 's stock had its "hol
    Read more...
Опубликовать